These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2219405)

  • 1. Reactivity of peripheral blood lymphocytes to recombinant interleukin-2 in kidney transplant recipients.
    Koda N; Oda T; Yokoyama M; Matsumoto A; Takeuchi M
    Transplant Proc; 1990 Oct; 22(5):2373-5. PubMed ID: 2219405
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.
    Smith AY; Citterio F; Welsh M; Kerman RH; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1462-4. PubMed ID: 2652467
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity in maintenance immunosuppression with and without cyclosporine in long-term kidney transplant recipients.
    Yamashita M; Aikawa A
    Transplant Proc; 2000 Nov; 32(7):1768-72. PubMed ID: 11119927
    [No Abstract]   [Full Text] [Related]  

  • 4. The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
    Kerr PG; Atkins RC
    Transplant Proc; 1990 Oct; 22(5):2121-2. PubMed ID: 2219316
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell activation and death (apoptosis) induced by IL-2: ultrastructural evidence.
    Capelli E; Barni S; Vaccarone R; Fortis C; Nano R
    Anticancer Res; 1996; 16(4A):1775-80. PubMed ID: 8712700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of interleukin 1- and interleukin 2-determinations in patients after kidney transplantation].
    Buchwald S; Friemel H; Plantikow A; Hudemann B; Bast R; Templin R
    Allerg Immunol (Leipz); 1990; 36(3):137-45. PubMed ID: 2256457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of recombinant interleukin 2 on peripheral blood lymphocytes in vitro. IV. Cytotoxicity of lymphocytes in patients with malignant tumors].
    Jíra M; Strejcek J; Faltýn J; Chodounský Z; Suchomelová M; Tomásová M; Zábojová E; Procházka M
    Cas Lek Cesk; 1988 Nov; 127(46):1422-4. PubMed ID: 3264757
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of spontaneous blastogenesis profiles in recipients of renal allografts.
    Yoon YS; Cheigh JS; Riggio RR; Stenzel KH; Suthanthiran M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1925. PubMed ID: 2652626
    [No Abstract]   [Full Text] [Related]  

  • 10. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for a possible Th2 bias in human renal transplant tolerance.
    Kusaka S; Grailer AP; Fechner JH; Burlingham WJ
    Transplant Proc; 1995 Feb; 27(1):225-6. PubMed ID: 7878978
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in urinary interleukin-2 in kidney transplant recipients.
    Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
    Transplant Proc; 1996 Jun; 28(3):1248-9. PubMed ID: 8658644
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxicity and IL 2 reactivity of cells from rejected or nonrejected allografts.
    Dallman MJ; Wood KJ; Morris PJ
    Transplant Proc; 1988 Apr; 20(2):226-8. PubMed ID: 3129832
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
    Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
    Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 stimulation of tumor necrosis factor synthesis by peripheral blood mononuclear cells in renal allograft rejection.
    Meulders Q; Rondeau E; Delarue F; Lacave R; Sraer JD
    Transplant Proc; 1990 Aug; 22(4):1987-8. PubMed ID: 2389504
    [No Abstract]   [Full Text] [Related]  

  • 17. B lymphocytes from stable renal transplant patients do not respond to exogenous lymphokines: comparison of azathioprine and cyclosporin treated patients.
    Weissgarten J; Ng C; Freidman E; Cardella CJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):393-4. PubMed ID: 2650158
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic kidney cells stimulate the production of immunoregulatory cytokines in mixed kidney lymphocyte culture.
    Takahara S; Moutabarrik A; Namiki M; Yamaguchi S; Kameoka H; Ishibashi M; Zaid D; Okuyama A
    Transplant Proc; 1993 Jun; 25(3):2314. PubMed ID: 8516912
    [No Abstract]   [Full Text] [Related]  

  • 20. [The response of peripheral blood lymphocytes from lung cancer patients to in-vitro treatment with recombinant interleukin-2].
    Pogodina ON; Karaseva NA; Ivanov VA
    Tsitologiia; 1997; 39(7):582-9. PubMed ID: 9490499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.